The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II clinical trial of neoadjuvant sasanlimab and stereotactic body radiation therapy as an in situ vaccine for cisplatin-ineligible muscle invasive bladder cancer (RAD VACCINE MIBC).
 
Raj Satkunasivam
Consulting or Advisory Role - Intuitive Surgical
Research Funding - Anchiano; Bristol-Myers Squibb; CoImmune; Merck; Natera; Pfizer; QED Therapeutics
 
Kelvin Lim
No Relationships to Disclose
 
Bin S. Teh
No Relationships to Disclose
 
Nestor F. Esnaola
Consulting or Advisory Role - AngioDynamics
 
Jeremy Slawin
No Relationships to Disclose
 
Jun Zhang
Honoraria - Genentech
Consulting or Advisory Role - Genentech
 
Brian Miles
Consulting or Advisory Role - EDAP Technomed
 
Michael Austin Brooks
No Relationships to Disclose
 
Maryam Anis
No Relationships to Disclose
 
Taliah Muhammad
No Relationships to Disclose
 
Andrew M. Farach
No Relationships to Disclose
 
Shu-Hsia Chen
Consulting or Advisory Role - Ansun Biopharma
Patents, Royalties, Other Intellectual Property - Ansun Biopharma; Ansun Biopharma (I)
 
Eleni Efstathiou
Honoraria - Astellas Pharma; Janssen-Cilag; Merck; Pfizer; Sanofi; Takeda
Consulting or Advisory Role - AstraZeneca; AstraZeneca; Bayer; Janssen Oncology; Myovant Sciences; Sanofi; Tokai Pharmaceuticals
Research Funding - Janssen-Cilag
 
Guru P. Sonpavde
Employment - Myriad Genetics (I)
Honoraria - UpToDate
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bicycle Therapeutics; Bristol-Myers Squibb; Eisai; EMD Serono; Exelixis; G1 Therapeutics; Genentech; Gilead Sciences; Infinity Pharmaceuticals; Janssen; Loxo/Lilly; Merck; Pfizer; Scholar Rock; Seagen
Speakers' Bureau - Medscape; Onclive; Physicans' Education Resource; Research to Practice
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); Gilead Sciences (Inst); Janssen (Inst); Predicine (Inst); QED Therapeutics (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
Other Relationship - Astellas Pharma; AstraZeneca; Bavarian Nordic; Bristol-Myers Squibb; Debiopharm Group; Elsevier; G1 Therapeutics; Mereo BioPharma; QED Therapeutics